Ozempic carries a self-pay price of $349 to $499 per month depending on the dose, making it one of the most expensive ongoing prescriptions many people will encounter. Several cheaper options exist, ranging from well-established generic medications that cost under $20 a month to newer compounded versions of the same active ingredient. The right alternative depends on whether you’re taking Ozempic for type 2 diabetes, weight loss, or both, and how much risk and uncertainty you’re willing to accept.
What Ozempic Actually Costs Right Now
Novo Nordisk lists the official self-pay price at $349 per month for the 0.25 mg, 0.5 mg, and 1 mg doses, and $499 per month for the 2 mg dose (with a “month” defined as 28 days). If you have commercial or private insurance that covers Ozempic, a manufacturer savings card can bring your copay down to as little as $25 per fill, with maximum savings of $100 per one-month prescription. To qualify, you need a valid three-month prescription, commercial insurance that covers a three-month fill, and a U.S. address.
That savings card has significant exclusions. If you’re on Medicare, Medicaid, TRICARE, VA benefits, or any similar federal or state program, you’re not eligible. And Medicare has been explicitly prohibited by law from covering weight-loss treatments since 2003, which means even people who initially got Ozempic covered for diabetes can lose access if their blood sugar improves enough that they no longer qualify as diabetic.
Compounded Semaglutide: Same Ingredient, Lower Price
Compounding pharmacies have been producing their own versions of semaglutide, typically at a fraction of Ozempic’s price. These pharmacies mix the medication to order, and many online telehealth platforms now connect patients directly to compounders. Monthly costs generally run between $100 and $300, though prices vary widely.
There’s an important catch. The FDA has raised specific concerns about compounded semaglutide products, particularly those using salt forms of the molecule like semaglutide sodium or semaglutide acetate. These are chemically different active ingredients from what’s in the approved drug. The FDA has stated it does not have information on whether these salt forms share the same properties as the original, and it is not aware of any lawful basis for using them in compounding. Compounded drugs are not reviewed for safety, effectiveness, or quality before reaching patients.
This doesn’t mean every compounded product is dangerous, but it does mean you’re accepting uncertainty that doesn’t exist with the FDA-approved version. If you go this route, look for pharmacies that use base semaglutide (not a salt form) and that hold accreditation from the Pharmacy Compounding Accreditation Board.
Metformin: The $4-a-Month Option
Metformin is one of the oldest and most widely prescribed diabetes medications in the world, and it costs roughly $4 a month with insurance, or $4 to $15 without it. For context, that’s less than a single lunch at most restaurants.
The tradeoff is effectiveness. People with type 2 diabetes and obesity lost an average of 5% to 6% of their body weight after a year on Ozempic, compared to about 2% after two years on metformin. That’s a meaningful gap. If you weigh 220 pounds, Ozempic might help you lose 11 to 13 pounds in a year, while metformin might produce around 4 pounds over twice the time.
Metformin works differently from Ozempic. Rather than mimicking a gut hormone that reduces appetite, it improves how your body uses insulin and reduces the amount of sugar your liver releases. It won’t give you the dramatic appetite suppression that GLP-1 drugs are known for. But for someone who primarily needs blood sugar control and can’t afford Ozempic, metformin remains a proven, safe, extraordinarily affordable starting point. Many doctors prescribe it as a first-line treatment for type 2 diabetes regardless of cost considerations.
Phentermine and Topiramate: Stronger Weight Loss, Still Cheap
If your main goal is weight loss rather than blood sugar management, the combination of phentermine and topiramate deserves a close look. These two generic medications, available individually or as the brand-name combination Qsymia, have demonstrated sustained weight loss of up to 13% of body weight. One study found an average 11% reduction in total body weight among patients who stayed on the combination for at least two years. That puts it in the same ballpark as Ozempic for weight loss, though the medications work through completely different mechanisms.
Generic versions of both drugs are available for as little as $20 per month combined, making this one of the most cost-effective prescription options for weight loss. Phentermine suppresses appetite through the central nervous system, while topiramate (originally developed for seizures and migraines) reduces food cravings and increases feelings of fullness through pathways that aren’t fully understood.
There are limitations. Phentermine is a controlled substance, and many doctors are cautious about prescribing it long-term. Side effects can include increased heart rate, tingling in the hands and feet, dry mouth, and cognitive fogginess (sometimes called “topi-brain” by patients on topiramate). It’s also not appropriate for people with uncontrolled high blood pressure or certain heart conditions. But for otherwise healthy people whose primary concern is losing weight at a manageable cost, this combination offers some of the best value available.
Berberine: The Supplement Option
Berberine, a compound found in several plants, went viral on social media as “nature’s Ozempic.” That label oversells it considerably, but it’s not completely without merit. A 2022 review of 18 studies found significant decreases in both weight and body mass index among people who took berberine, particularly at doses above 1 gram per day for more than eight weeks. It’s available over the counter for roughly $15 to $30 a month.
The reality check: that same review, conducted by the National Center for Complementary and Integrative Health, noted that many of the included studies had a high risk of bias and that individual study outcomes were inconsistent. No one has published data showing berberine produces anything close to the 5% to 13% body weight loss seen with prescription options. It may modestly help with blood sugar and cholesterol, but treating it as a substitute for Ozempic sets expectations that the evidence can’t support. Think of it as a potential complement to diet and exercise, not a replacement for prescription medication.
When Generic Semaglutide Might Arrive
Novo Nordisk’s U.S. patent on semaglutide is set to expire in 2032, but the timeline for actual generic availability shifted in late 2024. Novo Nordisk reached settlements with several major generic manufacturers, including Mylan (now part of Viatris), Sun Pharmaceutical, Dr. Reddy’s Laboratories, and Apotex. The specific terms are confidential, but these settlements likely include agreed-upon entry dates for generic versions, possibly with royalty payments to Novo Nordisk. Industry analysts expect generic semaglutide could reach the U.S. market before the 2032 patent expiration, though exactly when remains unclear.
When generics do arrive, prices should drop substantially, as they typically do for injectable biologics. Until then, the options above represent your best bets for spending less while still addressing weight or blood sugar goals.
Choosing Based on Your Situation
Your best alternative depends on what you’re treating. If you have type 2 diabetes and need blood sugar control above all else, metformin at $4 to $15 a month is the most proven and affordable starting point. If weight loss is your primary goal and you’re otherwise healthy, generic phentermine and topiramate at around $20 a month offers results that rival Ozempic at a tiny fraction of the cost. If you specifically want semaglutide but can’t afford the brand-name price, compounded versions are available, but come with real regulatory and quality concerns you should weigh carefully.
Insurance coverage also shapes the math. If you have commercial insurance and a type 2 diabetes diagnosis, Ozempic with a manufacturer savings card could cost you just $25 a month, which may actually be cheaper than some alternatives. Without insurance or on Medicare, the full self-pay price makes alternatives far more practical. Whatever route you take, the prescription options discussed here all have decades of safety data behind them, which counts for something when you’re choosing a medication you may take for years.